Trial Profile
Effect of abiraterone versus docetaxel in patients with Castration-Resistant Prostate Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2017
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Docetaxel
- Indications Prostate cancer
- Focus Therapeutic Use
- 24 May 2017 Results (n=303) presented at the 22nd Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
- 01 Jun 2015 New trial record
- 20 May 2015 Results presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.